FDA Approval Articles

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

11/18/2018 07:01 PM


Dr. Deol on the FDA Approval of Eltrombopag in Severe Aplastic Anemia
Abhinav Deol, MD, associate professor, Karmanos Cancer Institute, discusses the expanded FDA approval of eltrombopag (Promacta) in combination with standard immunosuppressive therapy for the treatment of newly diagnosed adult and pediatric patients ...

11/16/2018 10:30 PM

MD Magazine

Eltrombopag Gets FDA Approval for Adult, Pediatric Severe Aplastic Anemia
MD Magazine
The oral thrombopoietin receptor agonist (TPO-RA) has been previously approved by the FDA for SAA for patients with an insufficient response to IST, for adults and children with chronic immune thrombocytopenia (ITP) who are refractory to other ...
Novartis' blood disorder drug gets FDA approval for expanded useReuters
FDA approves Novartis (NVS) drug Promacta for first-line SAA and grants Breakthrough Therapy designationStreetInsider.com

all 26 news articles »

11/16/2018 10:14 PM


FDA approves new drug to treat travelers' diarrhea
The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever ...
FDA Approves Rifamycin for Traveler's DiarrheaMD Magazine

all 9 news articles »

11/16/2018 10:10 PM

Pharmacy Times

First-line Treatment for PTCL Granted FDA Approval Under New Review Pilot
Pharmacy Times
According to Richard Pazdur, MD, director of the FDA's Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products, the application also was approved by the FDA through the new Real-Time Oncology Review ...
FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilotFDA.gov
Seattle Genetics stock jumps 6% after new FDA approval for lymphoma treatmentMarketWatch
FDA Gives Speedy Approval to Brentuximab for Peripheral T-cell LymphomaAJMC.com Managed Markets Network
Specialty Pharmacy Times -Curetoday.com -FDA
all 39 news articles »

11/16/2018 07:42 PM

The Hutchinson News

Kansas company receives FDA approval for human trials of cancer treatment
The Hutchinson News
A Sterling company received approval today from the Food and Drug Administration to conduct human clinical trials for its new cancer treatment. Trials could begin early next year for Genzada Pharmaceuticals' cancer-fighting agent made from a lily that ...

11/16/2018 07:02 PM